Class Action Lawsuit Alleges OPTASE Eye Treatments Are Misbranded Due to Lack of FDA Approval
July 29, 2026 A class action lawsuit alleges that OPTASE eye treatments are misbranded because they include active ingredients that are not FDA-approved.
Lawsuit Filings
Class Action Lawsuit Claims OPTASE Eye Drops, Topicals Not FDA-Approved
September 24, 2025 A class action lawsuit claims several OPTASE products contain active ingredients that are banned or unapproved by the FDA.